Clinical Trial Update: Safety and Efficacy of TJ301 IV in Participants With Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial update on TJ301 IV for active ulcerative colitis reports safety and efficacy data from completed study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• TJ301

Snippet

Sponsor: I-Mab Biopharma HongKong Limited | Conditions: Active Ulcerative Colitis | Phase 2 | Status: COMPLETED